Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CLRB stock hub

Cellectar Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CLRBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

13.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CLRB

In the news

Latest news · CLRB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-170.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-108.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CLRB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001279704
Company name	Cellectar Biosciences, Inc.
Country	United States
Country code	US
Cusip	15117F880
Employees	11
Employees Change	-9%
Employees Change Percent	-45
Enterprise value	$357,953
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US15117F8804
Last refreshed	2026-05-10
Market cap	$13.1M
Market cap category	Nano-Cap
Price	$3.1
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	CLRB
Website	https://www.cellectar.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-165.78%
FCF yield	-175.92%
P/B ratio	1.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-21.8M
Net Income Growth Years	1%
Profit Per Employee	$-2M
ROA	-71.01
Roa5y	-96.15
ROCE	-224.7
ROE	-170.3
ROIC	-108.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-51.82%
Cagr15y	-56.55%
Cagr1y	-57.71%
Cagr3y	-58.63%
Cagr5y	-62.32%
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$15M
Cash	$13.2M
Current Assets	$14M
Current Liabilities	$4.7M
Debt	$409,586
Debt Equity	$0.04
Equity	$9.9M
Liabilities	$5.1M
Long Term Assets	$939,856
Long Term Liabilities	$309,397
Net Cash	$12.8M
Net Cash By Market Cap	$97.28
Net Cash Growth	-43.91%
Net Debt Equity	$-1.29
Tangible Book Value	$8M
Tangible Book Value Per Share	$1.89
WACC	6.41

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.96
Net Working Capital	$-3.8M
Quick ratio	2.78
Working Capital	$9.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-110.67%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.93%
1Y total return	-57.68%
200-day SMA	3.74
3Y total return	-92.92%
50-day SMA	2.91
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.24%
All Time High	1,799,964
All Time High Change	-100%
All Time High Date	2011-04-11
All Time Low	2.43
All Time Low Change	27.57%
All Time Low Date	2026-04-01
ATR	0.35
Beta	0.43
Beta1y	0.66
Beta2y	1.08
Ch YTD	5.09
High	3.23
High52	20.6
High52 Date	2025-06-04
High52ch	-84.95%
Low	2.88
Low52	2.43
Low52 Date	2026-04-01
Low52ch	27.57%
Ma50ch	6.68%
Premarket Change Percent	-2.73
Premarket Price	$3.21
Premarket Volume	27,490
Price vs 200-day SMA	-17.07%
RSI	55.26
RSI Monthly	26.91
RSI Weekly	43.05
Sharpe ratio	-0.24x
Sortino ratio	-0.32
Total Return	-110.67%
Tr YTD	5.09
Tr15y	-100%
Tr1m	12.73%
Tr1w	15.24%
Tr3m	1.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-1.78
Operating Income	$-23M
Price target	$10
Price Target Change	$223

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,084,147%
Float Percent	96.32%
Shares Insiders	3.68%
Shares Institutions	12.29%
Shares Out	4,240,129
Shares Qo Q	29.93%
Shares Yo Y	110.67%
Short Float	0.67%
Short Ratio	0.83
Short Shares	0.64

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-25.4M
Average Volume	2,892,829x
Bv Per Share	1.89
CAPEX	$-5,880
Ch10y	-99.93
Ch15y	-100
Ch1m	12.73
Ch1w	15.24
Ch1y	-57.68
Ch3m	1.97
Ch3y	-92.92
Ch5y	-99.24
Ch6m	-8.55
Change	-6.06%
Change From Open	-3.43
Close	3.3
Days Gap	-2.73
Depreciation Amortization	213,597
Dollar Volume	2,130,574.2
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-23M
EBITDA	$-22.8M
EPS	$-8.35
F Score	1
FCF	$-23.1M
FCF EV Yield	-6,460.09x
FCF Per Share	$-5.45
Financing CF	13,031,523
Fiscal Year End	December
Founded	2,002
Investing CF	-5,880
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-04
Last Report Date	2025-12-31
Last Split Date	2025-06-24
Last Split Type	Reverse
Last10k Filing Date	2026-03-04
Ma150	3.32
Ma150ch	-6.68%
Ma20	2.89
Ma20ch	7.19%
Net CF	-10,092,574
Next Earnings Date	2026-05-22
Open	3.21
Optionable	No
Position In Range	62.86
Post Close	3.1
Postmarket Change Percent	-2.9
Postmarket Price	$3.01
Ppne	910,076
Pre Close	3.3
Price Date	2026-05-08
Ptbv Ratio	1.64
Relative Volume	0.24x
Share Based Comp	2,263,704
Tr6m	-8.55%
Us State	New Jersey
Volume	687,282

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CLRB pay a dividend?

Capital-return profile for this ticker.

Performance

CLRB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CLRB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.3%

Float: +96.3% of shares outstanding

Insider ownership

+3.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CLRB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.3

Neutral momentum band

Price vs 200-day MA

-17.1%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

-0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CLRB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CLRB stock rating?

Cellectar Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CLRB analysis?

The full report lives at /stocks/CLRB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CLRB?

The latest report frames CLRB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CLRB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.